Home/Pipeline/Xgrast®

Xgrast®

Neutropenia (G‑CSF)

ApprovedCommercial

Key Facts

Indication

Neutropenia (G‑CSF)

Phase

Approved

Status

Commercial

Company

About Gennova Bio

Indian biotech delivering a portfolio of recombinant therapeutics and mRNA vaccines through innovative, scalable manufacturing.

View full company profile

Therapeutic Areas

Cardiovascular Neurology Nephrology Oncology Infectious Diseases